Loading...
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Immunology >> Adaptive Immunity >> B Cells >> CD
Anti-CD26 antibody - Carboxyterminal end
See all CD26 products (29) ...
Rabbit polyclonal to CD26 - Carboxyterminal end
ab28341 does not recognize other DPP family members.
Reacts with
Mouse, Rat, Human
Synthetic peptide based on the C terminal end of the catalytic domain of human CD26.
(Peptide available as ab41396.)
Liquid
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Preservative: 0.05% Sodium Azide
Constituents: 50% Glycerol
Concentration information loading...
Immunogen affinity purified
The antibody has been peptide-affinity purified.
Polyclonal
IgG
Immunology >> Immune System Diseases >> Antiviral Signaling >> HIV-related
Cancer >> Cancer Metabolism >> Response to hypoxia
Stem Cells >> Hematopoietic Progenitors >> Lymphoid >> T Lymphocytic Lineage
Stem Cells >> Hematopoietic Progenitors >> Lymphoid >> B Lymphocytic Lineage
Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Serine protease >> DPPs
Immunology >> Cell Type Markers >> CD >> Adhesion
Immunology >> Cell Type Markers >> CD >> Non-lineage
Immunology >> Adaptive Immunity >> T Cells >> CD
Immunology >> Adaptive Immunity >> B Cells >> CD
Western blot - CD26 antibody - Carboxyterminal end (ab28341)
(enlarge)
Our Abpromise guarantee covers the use of ab28341 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
WB: 1/1000 - 1/5000.Detects a band of approximately 110-120 kDa (predicted molecular weight: 88 kDa).(1/1000 (colorimetric) - 1/5000 (chemiluminescent). EDTA/EGTA treatment of tissues or lysates is required to see latent zymogen. Dilution optimised using Chromogenic detection.)
Cell surface glycoprotein receptor involved in the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation. Acts as a positive regulator of T-cell coactivation, by binding at least ADA, CAV1, IGF2R, and PTPRC. Its binding to CAV1 and CARD11 induces T-cell proliferation and NF-kappa-B activation in a T-cell receptor/CD3-dependent manner. Its interaction with ADA also regulates lymphocyte-epithelial cell adhesion. In association with FAP is involved in the pericellular proteolysis of the extracellular matrix (ECM), the migration and invasion of endothelial cells into the ECM. May be involved in the promotion of lymphatic endothelial cells adhesion, migration and tube formation. When overexpressed, enhanced cell proliferation, a process inhibited by GPC3. Acts also as a serine exopeptidase with a dipeptidyl peptidase activity that regulates various physiological processes by cleaving peptides in the circulation, including many chemokines, mitogenic growth factors, neuropeptides and peptide hormones. Removes N-terminal dipeptides sequentially from polypeptides having unsubstituted N-termini provided that the penultimate residue is proline.
Expressed specifically in lymphatic vessels but not in blood vessels in the skin, small intestine, esophagus, ovary, breast and prostate glands. Not detected in lymphatic vessels in the lung, kidney, uterus, liver and stomach (at protein level). Expressed in the poorly differentiated crypt cells of the small intestine as well as in the mature villous cells. Expressed at very low levels in the colon.
Belongs to the peptidase S9B family. DPPIV subfamily.
The extracellular cysteine-rich region is necessary for association with collagen, dimer formation and optimal dipeptidyl peptidase activity.
The soluble form (Dipeptidyl peptidase 4 soluble form also named SDPP) derives from the membrane form (Dipeptidyl peptidase 4 membrane form also named MDPP) by proteolytic processing.
N- and O-Glycosylated.
Phosphorylated. Mannose 6-phosphate residues in the carbohydrate moiety are necessary for interaction with IGF2R in activated T-cells. Mannose 6-phosphorylation is induced during T-cell activation.
Cell membrane. Apical cell membrane. Cell projection > invadopodium membrane. Cell projection > lamellipodium membrane. Cell junction. Membrane raft. Translocated to the apical membrane through the concerted action of N- and O-Glycans and its association with lipid microdomains containing cholesterol and sphingolipids. Redistributed to membrane rafts in T-cell in a interleukin-12-dependent activation. Its interaction with CAV1 is necessary for its translocation to membrane rafts. Colocalized with PTPRC in membrane rafts. Colocalized with FAP in invadopodia and lamellipodia of migratory activated endothelial cells in collagenous matrix. Colocalized with FAP on endothelial cells of capillary-like microvessels but not large vessels within invasive breast ductal carcinoma. Colocalized with ADA at the cell junction in lymphocyte-epithelial cell adhesion. Colocalized with IGF2R in internalized cytoplasmic vesicles adjacent to the cell surface and Secreted. Detected in the serum and the seminal fluid.
Target information above from: UniProt accessionP27487
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Western blot - CD26 antibody - Carboxyterminal end (ab28341)

All lanes : Anti-CD26 antibody - Carboxyterminal end (ab28341) at 1/1000 dilution
Lane 1 : Recombinant human DPP4/CD26 at 0.08 µg
Lane 2 : Recombinant human DPP4/CD26 at 0.04 µg
Lane 3 : Recombinant human DPP4/CD26 at 0.02 µg
Lane 4 : Recombinant human DPP4/CD26 at 0.01 µg
Predicted band size : 88 kDa
Observed band size : 114 kDa (why is the actual band size different from the predicted?)
Postranslational modifications and reduction lead to an apparent mass of 110-120 kDa on SDS-PAGE gels.
This product has been referenced in:
See all 2 publications for this product
Publishing research using ab28341? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:

All lanes : Anti-CD26 antibody - Carboxyterminal end (ab28341) at 1/1000 dilution
Lane 1 : Recombinant human DPP4/CD26 at 0.08 µg
Lane 2 : Recombinant human DPP4/CD26 at 0.04 µg
Lane 3 : Recombinant human DPP4/CD26 at 0.02 µg
Lane 4 : Recombinant human DPP4/CD26 at 0.01 µg
Predicted band size : 88 kDa
Observed band size : 114 kDa (why is the actual band size different from the predicted?)
Postranslational modifications and reduction lead to an apparent mass of 110-120 kDa on SDS-PAGE gels.
0
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
